Advertisement
Search for

Volume 136, Issue 5, Pages 1487-1490 (May 2009)


View previous. 8 of 80 View next.

Bloating and Abdominal Distention: Not So Poorly Understood Anymore!

Magnus SimrénCorresponding Author Informationemail address

published online 26 March 2009.

Refers to article:
Editorial Accompanies Article Abdominal Distention Results From Caudo-ventral Redistribution of Contents , 05 February 2009
Anna Accarino, Frederic Perez, Fernando Azpiroz, Sergi Quiroga, Juan–R. Malagelada
Gastroenterology
May 2009 (Vol. 136, Issue 5, Pages 1544-1551)
Abstract | Full Text | Full-Text PDF (1914 KB)

Article Outline

Bloating versus abdominal distention

Excessive amounts of gas in the GI tract?

Abnormal viscerosomatic responses

Conclusion

References

Copyright

See “Abdominal distention results from caudo-ventral redistribution of contents,” by Accarino A, Perez F, Azpiroz F, et al, on page 1544.

Bloating and abdominal distention are common and bothersome symptoms, for which clear pathophysiologic explanations have been lacking and available treatment options are limited. Bloating refers to the subjective sensation of abdominal swelling, whereas visible abdominal distention refers to an actual increase in abdominal girth.1 A recent population-based study demonstrated an age- and gender-adjusted prevalence in the US white population of bloating to be 19%, whereas visible distention was observed in 9%.2 In this survey, associations with female gender and somatization were seen, as well as with the presence of functional gastrointestinal (GI) disorders. This is in line with investigations in patients with functional bowel disorders, such as irritable bowel syndrome (IBS), where a majority complains of bloating with or without visible abdominal distention3, 4 and many find these to be among their most bothersome symptoms.5, 6 For long, abdominal bloating and visible distention have been poorly understood symptoms, but recent studies, especially from the Manchester and Barcelona groups, have shed some light on the different mechanisms involved in the generation of these symptoms.1, 7, 8 This is exemplified in the article by Accarino et al9 in this issue of Gastroenterology, where an important role for abnormal viscerosomatic responses with abdominophrenic incoordination and anterior wall protrusion was demonstrated.

Bloating versus abdominal distention 

return to Article Outline

By using abdominal inductance plethysmography10 and computed tomography (CT)11 it has been shown convincingly that abdominal distention is a real phenomenon in IBS that can reach up to 12 cm in certain patients.12 Although a sensation of bloating and visible abdominal distention often occurs together, this is not always the case, and in patients with IBS complaining of bloating, approximately half of the subjects objectively demonstrated visible abdominal distention,12 which is in line with reports from population-based studies.2 In this group of patients, constipation was more common,3, 12 and visceral hyposensitivity was observed frequently.13 The other 50% of patients complain of bloating alone without visible abdominal distention, and in this subgroup of patients, diarrhea predominance seems to be more common3 and the patients more often have signs of visceral hypersensitivity.12, 13 Moreover, in a recent barostat study from our group we also demonstrated that altered rectal perception was associated with the severity of bloating,14 further supporting this link. Based on these results, it seems as if bloating and visible abdominal distention share some features, but may arise from distinct pathophysiologic processes.

Excessive amounts of gas in the GI tract? 

return to Article Outline

A vast majority of patients with IBS complaining of bloating and abdominal distention are convinced that this is due to having “too much gas” within the GI tract. However, from the early studies using washout techniques15 and the recent studies from the Barcelona group, where a modern CT image analysis program has been used,16 it seems clear that excessive amounts of gas in the GI tract is not the main problem in the majority of patients with functional bowel disorder, although abnormal colonic fermentation has been suggested in some studies.17 However, a defect handling of exogenous gas loads within the GI tract in patients with bloating has been demonstrated convincingly in several studies of patients with IBS complaining of bloating,18, 19 and the following gas retention reproduced their symptoms.18 In fact, the majority of patients included in these studies demonstrated gas retention and/or enhanced perception of the exogenous gas load, pointing toward a combination of impaired transit and enhanced sensitivity being responsible for the symptoms. From a mechanistic point of view, altered GI reflex activity20 and enhanced sensitivity to nutrients19, 21 have been found to be important factors involved in the impaired gas transit in these patients, as well as in symptom perception. Moreover, by using a scintigraphic technique, the small intestine was found to be responsible for the ineffective gas propulsion in patients complaining of bloating,22, 23 which is probably contrary to what the majority of researchers had expected; the colon seems to be a more logical choice.

Taken together, these findings tell us that IBS patients do not necessarily need to produce more gas to have gas-related symptoms, but these may instead be owing to motor dysfunction, creating a transport problem, and enhanced visceral sensitivity. Moreover, as will be discussed, focal gas pooling may release abnormal viscerosomatic responses, resulting in bloating and visible abdominal distention.

Abnormal viscerosomatic responses 

return to Article Outline

It has been proposed that depression of the diaphragm, excess lumbar lordosis, weak abdominal musculature, and voluntary protrusion of the abdomen may be of importance in the generation of bloating and abdominal distention, but none of these alterations could be confirmed in an early CT study,11 or in a small study from Australia where the abdominal wall muscle activity in IBS seemed to be normal.24 However, by using electromyography of the abdominal wall and the diaphragm, and modern CT image analysis, the group from Barcelona, in a number of careful studies in healthy volunteers and patients, has provided important new knowledge regarding the generation of abdominal distention in patients with functional GI disorders. In these studies, it was demonstrated that abdominal accommodation to volume loads is an active process involving abdominophrenic muscular responses25 and that patients with IBS and bloating have impaired viscerosomatic reflexes and abdominal wall dystony with failed tonic contraction of the abdominal wall and paradoxical relaxation of the internal oblique in response to a colonic gas load.26 In the present issue of Gastroenterology, these initial pioneering studies are followed by another very interesting study, where a relatively large group of patients with bloating as their predominant complaint and healthy volunteers were investigated with abdominal CT scan,9 with dedicated software for analyzing the gas content and intra-abdominal volumes.27 Of great interest, patients with bloating as part of a functional disorder were compared with patients with severe intestinal dysmotility and bloating, and both groups underwent CT scans during basal conditions and during a severe bloating episode. No clear group differences were observed in the basal state. However, different mechanisms behind the bloating episodes were detected in these 2 groups, where patients with intestinal dysmotility demonstrated a true increase in total abdominal volume with cephalic displacement of the diaphragm, whereas the patients with a functional disorder had a very modest increment of the abdominal volume; instead the abdominal distention was related to diaphragmatic descent, resulting in abdominophrenic displacement and ventrocaudal redistribution of contents.

These findings are of potentially great value in explaining the bothersome symptoms of bloating and visible abdominal distention; a minor, although significant, increase in intestinal gas, as demonstrated in this study, may drive the generation of abdominal distention through the presence of abnormal viscerosomatic reflexes. However, this study has some shortcomings. The group with a functional cause of its abdominal distention was selected based on the presence of severe symptoms of bloating and abdominal distention, and comprised patients with IBS with constipation and mixed bowel habits, as well as a group of patients with functional bloating, but no patient with IBS with diarrhea was included. Therefore, from this study, the generalizability of the findings to all patients with a functional bowel disorder is unclear, and the relevance of the findings is confined to patients with visible abdominal distention, not to patients with the sensation of bloating alone. Follow-up studies are now needed in different patient groups with comparisons between different subgroups of patients. Moreover, the role of the body mass index was not clarified in this study.

A new and potentially very important mechanism behind abdominal distention in functional GI disorders has been demonstrated, and the next steps are now to evaluate its relevance relative to other proposed underlying mechanisms, and to find a potential treatment option to reduce these bothersome symptoms.

Conclusion 

return to Article Outline

Potential mechanisms behind the bothersome symptoms of bloating and visible abdominal distention have emerged in recent years (Figure 1). Impairment of intestinal gas transit seems to play an important role, implicating a link to altered GI motility—a frequent finding in patients with functional GI disorders. Visceral hypersensitivity, one of the main pathophysiologic factors in functional GI disorders, is of importance for symptom generation, especially in those with bloating without visible abdominal distention. Abnormal viscerosomatic responses may result from focal pooling of gut content with abdominophrenic incoordination and abdominal wall protrusion as a consequence. Other less well-established/-studied factors of potential importance are abnormal mucosal immune activation,28 altered bacterial flora,29, 30, 31 sex hormones,2 and psychological factors, including somatization.2, 3 The next step now would be to evaluate the relative importance of these different factors and the interplay between them. Will subgrouping of patients with bloating alone versus bloating with abdominal distention based on the presence/absence of different pathophysiologic factors be clinically relevant? Moreover, from the patients' point of view, it seems to be of utmost importance to translate these findings into the development of potential treatment options to reduce the severity of bloating and visible abdominal distention. This will be a major step forward for the patients and their treating physicians!


View full-size image.

Figure 1. Potential mechanisms behind bloating and visible abdominal distention in functional GI disorders.


References 

return to Article Outline

1. 1Houghton LA, Whorwell PJ. Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders. Neurogastroenterol Motil. 2005;17:500–511. MEDLINE | CrossRef

2. 2Jiang X, Locke GR, Choung RS, et al. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut. 2008;57:756–763. CrossRef

3. 3Chang L, Lee OY, Naliboff B, et al. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. Am J Gastroenterol. 2001;96:3341–3347. MEDLINE | CrossRef

4. 4Schmulson M, Lee OY, Chang L, et al. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol. 1999;94:2929–2935. MEDLINE | CrossRef

5. 5Lembo T, Naliboff B, Munakata J, et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol. 1999;94:1320–1326. MEDLINE | CrossRef

6. 6Maxton DG, Morris JA, Whorwell PJ. Ranking of symptoms by patients with the irritable bowel syndrome. BMJ. 1989;299:1138.

7. 7Azpiroz F. Intestinal gas dynamics: mechanisms and clinical relevance. Gut. 2005;54:893–895. MEDLINE | CrossRef

8. 8Quigley EM. From comic relief to real understanding; how intestinal gas causes symptoms. Gut. 2003;52:1659–1661. MEDLINE | CrossRef

9. 9Accarino A, Perez F, Azpiroz F, et al. Abdominal distension results from caudo-ventral redistribution of contents. Gastroenterology. 2009;136:1544–1551. Abstract | Full Text | Full-Text PDF (1914 KB) | CrossRef

10. 10Lewis MJ, Reilly B, Houghton LA, et al. Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome. Gut. 2001;48:216–220. MEDLINE | CrossRef

11. 11Maxton DG, Martin DF, Whorwell PJ, et al. Abdominal distension in female patients with irritable bowel syndrome: exploration of possible mechanisms. Gut. 1991;32:662–664. MEDLINE | CrossRef

12. 12Houghton LA, Lea R, Agrawal A, et al. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology. 2006;131:1003–1010. Abstract | Full Text | Full-Text PDF (271 KB) | CrossRef

13. 13Agrawal A, Houghton LA, Lea R, et al. Bloating and distention in irritable bowel syndrome: the role of visceral sensation. Gastroenterology. 2008;134:1882–1889. Abstract | Full Text | Full-Text PDF (279 KB) | CrossRef

14. 14Posserud I, Syrous A, Lindstrom L, et al. Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology. 2007;133:1113–1123. Abstract | Full Text | Full-Text PDF (475 KB) | CrossRef

15. 15Lasser RB, Bond JH, Levitt MD. The role of intestinal gas in functional abdominal pain. N Engl J Med. 1975;293:524–526. MEDLINE

16. 16Accarino A, Perez F, Azpiroz F, et al. Intestinal gas and bloating: effect of prokinetic stimulation. Am J Gastroenterol. 2008;103:2036–2042. CrossRef

17. 17King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet. 1998;352:1187–1189. Abstract | Full Text | Full-Text PDF (40 KB) | CrossRef

18. 18Serra J, Azpiroz F, Malagelada JR. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut. 2001;48:14–19. MEDLINE | CrossRef

19. 19Serra J, Salvioli B, Azpiroz F, et al. Lipid-induced intestinal gas retention in irritable bowel syndrome. Gastroenterology. 2002;123:700–706. Abstract | Full Text | Full-Text PDF (107 KB) | CrossRef

20. 20Passos MC, Serra J, Azpiroz F, et al. Impaired reflex control of intestinal gas transit in patients with abdominal bloating. Gut. 2005;54:344–348. MEDLINE | CrossRef

21. 21Simrén M, Abrahamsson H, Björnsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut. 2001;48:20–27. MEDLINE | CrossRef

22. 22Salvioli B, Serra J, Azpiroz F, et al. Origin of gas retention and symptoms in patients with bloating. Gastroenterology. 2005;128:574–579. Abstract | Full Text | Full-Text PDF (173 KB) | CrossRef

23. 23Salvioli B, Serra J, Azpiroz F, et al. Impaired small bowel gas propulsion in patients with bloating during intestinal lipid infusion. Am J Gastroenterol. 2006;101:1853–1857. MEDLINE | CrossRef

24. 24McManis PG, Newall D, Talley NJ. Abdominal wall muscle activity in irritable bowel syndrome with bloating. Am J Gastroenterol. 2001;96:1139–1142. MEDLINE | CrossRef

25. 25Villoria A, Azpiroz F, Soldevilla A, et al. Abdominal accommodation: a coordinated adaptation of the abdominal wall to its content. Am J Gastroenterol. 2008;103:2807–2815.

26. 26Tremolaterra F, Villoria A, Azpiroz F, et al. Impaired viscerosomatic reflexes and abdominal-wall dystony associated with bloating. Gastroenterology. 2006;130:1062–1068. Abstract | Full Text | Full-Text PDF (195 KB) | CrossRef

27. 27Perez F, Accarino A, Azpiroz F, et al. Gas distribution within the human gut: effect of meals. Am J Gastroenterol. 2007;102:842–849. MEDLINE | CrossRef

28. 28Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009;104:392–400. CrossRef

29. 29Kassinen A, Krogius-Kurikka L, Makivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007;133:24–33. Abstract | Full Text | Full-Text PDF (694 KB) | CrossRef

30. 30Posserud I, Stotzer PO, Bjornsson ES, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2007;56:802–808. MEDLINE | CrossRef

31. 31Agrawal A, Houghton LA, Morris J, et al. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther. 2008;Sep 17 [Epub ahead of print].

Department of Internal Medicine, Sahlgrenska University Hospital, Göteborg, Sweden

Corresponding Author InformationReprint Requests Address requests for reprints to: Magnus Simrén, MD, PhD, Department of Internal Medicine, Sahlgrenska University Hospital, S-41345 Gothenburg, Sweden

 Conflicts of Interest The author discloses no conflicts.

PII: S0016-5085(09)00447-8

doi:10.1053/j.gastro.2009.03.023


View previous. 8 of 80 View next.